Cargando…
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
BACKGROUND: The toxic effect of doxorubicin on the heart limits its clinical usage in cancer therapy. This work intended to investigate, for the first time, the efficacy of rifampicin administration against doxorubicin-induction of cardiotoxicity in mice. Forty adult male albino mice were distribute...
Autores principales: | Basal, Omnia A., Zahran, Rasha F., Saad, Entsar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441914/ https://www.ncbi.nlm.nih.gov/pubmed/37603165 http://dx.doi.org/10.1186/s43044-023-00403-z |
Ejemplares similares
-
Glycine protects against doxorubicin-induced heart toxicity in mice
por: Shosha, Mayada I., et al.
Publicado: (2023) -
Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice
por: Hu, Xiaoping, et al.
Publicado: (2020) -
Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023) -
Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
por: Fan, Rui, et al.
Publicado: (2023) -
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)